|
Market Cap | 14.96M | EPS (ttm) | -0.47 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 31.10% |
P/S | - | EPS next 5Y | - |
P/B | 1.10 | EPS Q/Q | 73.81% |
Dividend | - | Sales Q/Q | - |
Insider Own | 16.97% | Inst Own | 1.21% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.11% | Earnings | Nov 15/b |
Analyst Recom | 1.00 | Target Price | 5.97 |
Avg Volume | 210.32K | 52W Range | 0.35 - 1.68 |
|
|
|
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada. |
|
|
|
Market Cap | 1.43M | EPS (ttm) | -5.52 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.10 | EPS next 5Y | - |
P/B | 0.17 | EPS Q/Q | 75.38% |
Dividend | - | Sales Q/Q | -20.16% |
Insider Own | 19.16% | Inst Own | 5.85% |
Insider Trans | 0.02% | Inst Trans | -92.28% |
Short Float | 2.11% | Earnings | Apr 05/b |
Analyst Recom | 1.00 | Target Price | 7.00 |
Avg Volume | 1.07M | 52W Range | 0.25 - 5.20 |
|
|
Apr-23-24 07:30AM
|
Reliance Global Group Inc.: Invitation to EF Hutton Annual Global Conference
(Newsfile) |
Apr-04-24 01:52PM
|
RELI Stock Earnings: Reliance Global Group Reported Results for Q4 2023
(InvestorPlace) +43.24% |
09:30AM
|
New to The Street TV Announces its Next Two Shows Broadcastings with Five Business Guest Interviews, Episode 566 Airs on Bloomberg TV as A Sponsored Programming Tonight, Thursday, April 4, 2024, at 9:30 PM PT, and Episode 567 Airs on The FOX Business Network, Monday, April 8, 2024, at 10:30 PM PT
(GlobeNewswire) |
08:00AM
|
Reliance Global Group's Revenue Grows by 17% and 40% in 2023 Compared to 2022 and 2021, respectively
(GlobeNewswire) |
Apr-03-24 08:30AM
|
Reliance Global Group Schedules Fourth Quarter 2023 Financial Results and Business Update Conference Call
(GlobeNewswire) |
Jan-30-24 08:30AM
|
RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform
(GlobeNewswire) -7.88% |
Jan-19-24 09:30AM
|
New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT
(GlobeNewswire) +7.58% |
Dec-19-23 08:30AM
|
Reliance Global Group Provides Year-End Update on RELI Exchange
(GlobeNewswire) -5.75% |
Dec-08-23 09:46AM
|
New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT
(GlobeNewswire) |
Dec-07-23 09:20AM
|
New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT
(GlobeNewswire) |
|
Reliance Global Group, Inc. is a diversified company, which engages in the business of insurance market and other relates sectors. It focuses on acquisition strategy, wholesale, and retail insurance agencies. The company was founded on August 2, 2013 and is headquartered in Lakewood, NJ. |
|
|
|
Market Cap | 3.23M | EPS (ttm) | -10.99 |
P/E | - | EPS this Y | 14.47% |
Forward P/E | - | EPS next Y | 18.46% |
PEG | - | EPS past 5Y | 45.52% |
P/S | 0.36 | EPS next 5Y | - |
P/B | 0.61 | EPS Q/Q | 70.94% |
Dividend | - | Sales Q/Q | -83.07% |
Insider Own | 12.32% | Inst Own | 16.65% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.78% | Earnings | Feb 08/a |
Analyst Recom | 1.00 | Target Price | 45.00 |
Avg Volume | 12.98K | 52W Range | 3.60 - 37.20 |
|
|
|
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY. |
|
| |
|
Market Cap | 40.88M | EPS (ttm) | -0.12 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 1.15 | EPS Q/Q | -100.11% |
Dividend | - | Sales Q/Q | - |
Insider Own | 55.91% | Inst Own | 47.45% |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 63.92K | 52W Range | 4.01 - 11.50 |
|
|
|
Pegasus Digital Mobility Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on March 30, 2021 and is headquartered in George Town, Cayman Islands. |
|
|
|
Market Cap | 159.88M | EPS (ttm) | 0.04 |
P/E | 189.90 | EPS this Y | 341.67% |
Forward P/E | 18.57 | EPS next Y | 129.24% |
PEG | 9.49 | EPS past 5Y | - |
P/S | 1.27 | EPS next 5Y | 20.00% |
P/B | 3.05 | EPS Q/Q | -34.00% |
Dividend | - | Sales Q/Q | 10.20% |
Insider Own | 12.24% | Inst Own | 73.11% |
Insider Trans | 0.00% | Inst Trans | 0.37% |
Short Float | 1.15% | Earnings | May 09/b |
Analyst Recom | 1.00 | Target Price | 14.83 |
Avg Volume | 46.09K | 52W Range | 7.41 - 11.44 |
|
|
|
InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Patient Services and Device Solutions segments. The Patient Services segment involves the durable medical equipment, clinic-to-home health care, logistics and billing, and oncology business. The Device Solutions segment includes the sale or rent of new and pre-owned pole-mounted and ambulatory infusion pumps, treatment-related consumables, biomedical recertification, maintenance and repair services for oncology practices. The company was founded by Steven E. Watkins in August 2005 and headquartered in Rochester Hills, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lachance Carrie | President and COO | Mar 01 '24 | Option Exercise | 0.00 | 50,000 | 0 | 193,745 | Mar 05 08:00 PM | Chupa Addam | Executive VP and CIO | Feb 09 '24 | Option Exercise | 0.00 | 3,000 | 0 | 22,393 | Feb 13 08:51 PM | Malhotra R. Rimmy | Director | Sep 06 '23 | Sale | 10.09 | 12,500 | 126,073 | 45,000 | Sep 08 06:38 PM | Malhotra R. Rimmy | Director | Sep 05 '23 | Sale | 10.19 | 5,000 | 50,972 | 57,500 | Sep 05 06:16 PM | Malhotra R. Rimmy | Director | Sep 01 '23 | Sale | 10.24 | 12,500 | 128,036 | 62,500 | Sep 05 06:16 PM |
|
|
| |
|
Market Cap | 90.98M | EPS (ttm) | 0.42 |
P/E | 24.08 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -11.82% |
P/S | 0.37 | EPS next 5Y | - |
P/B | 0.70 | EPS Q/Q | 32.52% |
Dividend | - | Sales Q/Q | -11.00% |
Insider Own | 81.64% | Inst Own | 4.71% |
Insider Trans | 0.02% | Inst Trans | 1.87% |
Short Float | 0.23% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.89K | 52W Range | 10.03 - 13.41 |
|
|
|
Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Silva Juan Luis | V.P. Plant Superintendent | Apr 01 '24 | Buy | 11.30 | 100 | 1,130 | 208 | Apr 01 05:22 PM | Bridgford Allan Jr. | Consultant | Mar 20 '24 | Buy | 11.39 | 15 | 171 | 43,000 | Mar 28 02:39 PM | Bridgford Richard Eugene | V.P. Ind. Relations & Safety | Mar 18 '24 | Buy | 10.62 | 195 | 2,071 | 2,295 | Mar 18 06:16 PM | Bridgford Allan Jr. | Consultant | Mar 18 '24 | Buy | 10.75 | 134 | 1,440 | 42,965 | Mar 18 06:15 PM | Bridgford Allan Jr. | Consultant | Mar 15 '24 | Buy | 10.77 | 82 | 883 | 42,831 | Mar 18 06:15 PM |
|
|
|
|
Market Cap | 8.87M | EPS (ttm) | -0.34 |
P/E | - | EPS this Y | -970.90% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.63 | EPS next 5Y | - |
P/B | 13.83 | EPS Q/Q | -679.80% |
Dividend | - | Sales Q/Q | 275.00% |
Insider Own | 67.49% | Inst Own | 0.34% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.74% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 171.43K | 52W Range | 0.41 - 22.40 |
|
|
|
Northann Corp. engages in the manufacture, wholesale, and retail of the 3D printed vinyl flooring panels and other decorative panels in North America, Europe, and internationally. The company offers its products under the Benchwick brand name. Northann Corp. was founded in 2013 and is based in Elk Grove, California. |
|
|
|